Michael W. Freeman
Stock Analyst at Raymond James
(1.41)
# 3,624
Out of 5,088 analysts
48
Total ratings
32.4%
Success rate
-0.8%
Average return
Main Sectors:
Stocks Rated by Michael W. Freeman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: PRN Profound Medical Corp. | Reiterated: Buy | n/a | $8.21 | - | 6 | Aug 7, 2026 | |
| TSX: VHI Vitalhub Corp. | Reiterated: Buy | n/a | $7.71 | - | 7 | Aug 7, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Reiterated: Buy | n/a | $4.20 | - | 6 | Aug 7, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $36.00 | $33.67 | +6.92% | 1 | Jul 6, 2026 | |
| TSX: AIDX Healwell AI Inc. | Reiterated: Buy | $3.00 → $2.50 | $0.70 | +257.14% | 5 | Mar 25, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Reiterated: Buy | $6.00 → $7.00 | $4.56 | +53.51% | 2 | Nov 18, 2025 | |
| TSX: MDP Medexus Pharmaceuticals Inc. | Reiterated: Buy | $8.00 | $5.04 | n/a | 9 | Aug 14, 2025 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | $11.18 | $12.41 | n/a | 7 | Aug 5, 2025 | |
| NGEN NervGen Pharma | Reiterated: Buy | $3.21 → $4.28 | $1.44 | n/a | 3 | Jun 11, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Reiterated: Buy | $8.00 | $11.40 | n/a | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1.50 | $0.14 | n/a | 1 | Nov 18, 2024 |
Profound Medical Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.21
Upside: -
Vitalhub Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.71
Upside: -
WELL Health Technologies Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.20
Upside: -
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $36.00
Current: $33.67
Upside: +6.92%
Healwell AI Inc.
Mar 25, 2026
Reiterated: Buy
Price Target: $3.00 → $2.50
Current: $0.70
Upside: +257.14%
HLS Therapeutics Inc.
Nov 18, 2025
Reiterated: Buy
Price Target: $6.00 → $7.00
Current: $4.56
Upside: +53.51%
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Reiterated: Buy
Price Target: $8.00
Current: $5.04
Upside: n/a
Bausch Health Companies Inc.
Aug 5, 2025
Reiterated: Hold
Price Target: $11.18
Current: $12.41
Upside: n/a
NervGen Pharma
Jun 11, 2025
Reiterated: Buy
Price Target: $3.21 → $4.28
Current: $1.44
Upside: n/a
Knight Therapeutics Inc.
Mar 12, 2025
Reiterated: Buy
Price Target: $8.00
Current: $11.40
Upside: n/a
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.14
Upside: n/a